• Tacrolimus
  • Carcinoembryonic Antigen (CEA), Peritoneal Fluid
  • Opioid-use Disorder Pain Management Genotyping Panel
  • Blastomyces Antibody, Spinal Fluid
  • Transferrin Receptor, Soluble
  • Growth Hormone Binding Protein (GHBP)
  • Ataxia telangiectasia
  • Mumps Virus Antibody, IgM
  • Culture, Prostatic Secretion
  • Myelin Basic Protein, CSF
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test

LOINC
Access to BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance is restricted.